证券代码：688101 证券简称：三达膜 三达膜环境技术股份有限公司 投资者关系活动记录表 （2024 年陕西辖区上市公司投资者集体接待日暨 2023 年度 业绩说明会） 三达膜环境技术股份有限公司 投资者关系活动记录表 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 投资者关系活动类别 □新闻发布会 □路演活动 □现场参观 □一对一沟通 □其他 参与单位名称 全体投资者均可通过网络互动的方式参加本次说明会 ...

关于参加"2024 年陕西辖区上市公司投资者集体接待 日暨 2023 年度业绩说明会"的公告 证券代码：688101 证券简称：三达膜 公告编号：2024-028 三达膜环境技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 为促进上市公司规范运作、健康发展，增强上市公司信息透明度， 加强与广大投资者沟通交流，进一步提升投资者关系管理水平，陕西 上市公司协会根据陕西证监局工作部署，联合深圳市全景网络有限公 司举办"2024年陕西辖区上市公司投资者集体接待日暨2023年度业绩 说明会"。 届时，公司总经理及相关高管人员将通过互动平台与投资者进行 网络沟通和交流。为充分尊重投资者、提升交流的针对性，现就公司 2023年度业绩说明会提前向投资者公开征集问题，广泛听取投资者的 意见和建议。投资者可于2024年5月21日（星期二）16：00前访问"全 景路演"（https://ir.p5w.net/zj），进入问题征集专题页面。公司 将在2023年度业绩说明会上，对投资者普遍关注的问题进行回答。欢 迎广大投资者积极参 ...

Financial Performance - The company's operating revenue for Q1 2024 reached ¥284,327,519.11, representing a year-on-year increase of 39.99%[5] - Net profit attributable to shareholders was ¥66,745,405.55, reflecting a growth of 35.91% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥59,848,176.28, which is an increase of 49.94% year-on-year[5] - The basic earnings per share (EPS) was ¥0.20, up by 33.33% from the previous year[5] - Total operating revenue for Q1 2024 reached ¥284.33 million, a 40% increase from ¥203.11 million in Q1 2023[19] - Net profit for Q1 2024 was ¥68.27 million, representing a 35.8% increase compared to ¥50.27 million in Q1 2023[20] - Operating profit for Q1 2024 was ¥78.18 million, an increase of 40.0% from ¥55.84 million in Q1 2023[19] - Basic earnings per share for Q1 2024 were ¥0.20, up from ¥0.15 in Q1 2023[20] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥5,566,371,943.64, a slight increase of 0.51% from the end of the previous year[6] - As of March 31, 2024, the total current assets amounted to RMB 3,201,631,938.62, an increase from RMB 3,160,726,424.45 as of December 31, 2023, reflecting a growth of approximately 1.3%[14] - The total assets as of March 31, 2024, were RMB 5,566,371,943.64, slightly up from RMB 5,538,253,296.44, showing a growth of about 0.5%[15] - The total liabilities decreased to RMB 1,637,100,720.10 from RMB 1,677,256,889.48, indicating a reduction of approximately 2.4%[16] - The company reported a total equity of RMB 3,929,271,223.54 as of March 31, 2024, up from RMB 3,860,996,406.96, representing an increase of about 1.8%[16] Cash Flow - Cash flow from operating activities was ¥56,372,725.95, with significant growth attributed to increased cash receipts from sales[7] - Cash flow from operating activities for Q1 2024 was ¥56.37 million, a significant recovery from a negative cash flow of ¥41.44 million in Q1 2023[22] - The company experienced a net cash increase of ¥207.77 million in Q1 2024, contrasting with a decrease of ¥664.59 million in Q1 2023[23] - Cash and cash equivalents increased to RMB 887,787,391.84 from RMB 680,763,242.67, representing a significant increase of about 30.5%[14] - Cash and cash equivalents at the end of Q1 2024 totaled ¥880.87 million, up from ¥690.48 million at the end of Q1 2023[23] - The company reported an investment cash inflow of ¥568.93 million in Q1 2024, compared to no inflow in Q1 2023[23] Shareholder Information - The company reported a total of 12,285 common shareholders at the end of the reporting period[10] - Major shareholders include Sanda Membrane Technology (Singapore) Co., Ltd., holding 43.36% of shares, and Qingyuan (China) Co., Ltd., holding 25.66%[10] Research and Development - Research and development (R&D) expenses totaled ¥13,108,628.08, accounting for 4.61% of operating revenue, a decrease of 1.14 percentage points year-on-year[6] - Research and development expenses increased to ¥13.11 million in Q1 2024, compared to ¥11.67 million in Q1 2023[19] Inventory and Receivables - The accounts receivable rose to RMB 842,168,557.25 from RMB 813,646,572.56, reflecting an increase of about 3.5%[14] - The inventory decreased to RMB 735,508,835.12 from RMB 749,019,593.63, indicating a decline of approximately 1.8%[14] Other Information - The weighted average return on equity (ROE) increased by 0.37 percentage points to 1.74%[6] - The short-term borrowings and other current liabilities were not detailed in the provided data, indicating a stable financial position[15] - The company has not disclosed any significant new product developments or market expansion strategies in the current report[13]

容诚审字[2024]361Z0037 号 容诚会计师事务所(特殊普通合伙) RSM 容诚 审计报告 三达膜环境技术股份有限公司 中国 · 北京 您可使用手机 "扫一扫"或进入"胜册会计师行业绩一遗管业具有执业许可的会计师事务所出身 您可使用手机 "扫一扫"或进入"注册会计师行业统一监管平台（http://za用6编码:.京24688SWUL 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 审计报告 | 1-6 | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4 | | 6 | 母公司资产负债表 | 5 | | 7 | 母公司利润表 | 6 | | 8 | 母公司现金流量表 | 7 | | 9 | 母公司所有者权益变动表 | 8 | | 10 | 财务报表附注 | 9 - 136 | 审计报告 容诚审字[2024]361Z0037 号 三达膜环境技术股份有限公司全体股东: 一、审计意见 我们审计了三达膜环境技术股份有限公司(以下简称三达膜公司)财务报表, 包括 ...

（一）个人工作履历、专业背景及任职情况 关瑞章，男，1953年出生，中国国籍，无境外永久居留权，毕业于英国白金 汉大学，获生物科学系博士学位。原集美大学党委常委、副校长、二级教授，中 科院水生所博导，享受国务院政府津贴。曾任厦门水产学院助教、讲师，集美大 学水产学院副教授、教授、 硕士生导师、中科院水生所博士生导师，集美大学 党委常委、副校长，中国水产学会副理事长，国家教育部水产学科指导委员会委 员，教育部"鳗鲡现代产业技术工程研究中心"主任，2013年8月退休；现任本 公司独立董事，同时担任福建天马科技集团股份有限公司独立董事。 三达膜环境技术股份有限公司 独立董事述职报告 三达膜环境技术股份有限公司 2023 年度独立董事述职报告 作为三达膜环境技术股份有限公司（以下简称"公司"）的独立董事，按照 《公司法》《证券法》《上市公司治理准则》《上海证券交易所科创板股票上市 规则》《国务院办公厅关于上市公司独立董事制度改革的意见》《上市公司独立 董事管理办法》等法律、法规、规范性文件及《公司章程》《独立董事制度》的 有关规定，本人在2023年度的工作中，本着恪尽职守、勤勉尽责的工作态度，认 真行使职权，忠实履行 ...

RSM 容诚 内部控制审计报告 三达膜环境技术股份有限公司 容诚审字[2024]361Z0036 号 容诚会i ISE 容诚会计师事务所 (特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mol.gov.cn）"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mackgr.co）"进行查询 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制审计报告 容诚审字[2024]361Z0036 号 三达膜环境技术股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了三达膜坏境技术股份有限公司(以下简称"三达膜公司")2023 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是三达 ...

证券代码：688101 证券简称：三达膜 公告编号：2024-025 三达膜环境技术股份有限公司 第四届监事会第二十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承 担法律责任。 三达膜环境技术股份有限公司（以下简称"公司"）第四届监事会 第二十七次会议于 2024 年 4 月 25 日在公司会议室以现场方式召开，会 议通知于 2024 年 4 月 15 日以通讯方式发出。本次会议由监事会主席林 莉女士主持，应到监事 3 名，实到监事 3 名，会议的召开符合《中华人 民共和国公司法》《公司章程》及《监事会议事规则》的相关规定。经与 会监事审议和投票表决，会议决议如下： 一、审议通过《关于<2023 年年度报告及其摘要>的议案》 监事会认为：公司《2023 年年度报告》及其摘要的编制和审议程序 符合相关法律、法规、规范性文件及《公司章程》的有关规定，所包含 的内容真实、准确、完整地反映了本公司 2023 年度经营管理和财务状况 等各方面的实际情况。不存在任何虚假记载、误导性陈述或重大遗漏， 未发现参与公司 2023 年年 ...

三达膜环境技术股份有限公司 独立董事述职报告 三达膜环境技术股份有限公司 2023 年度独立董事述职报告 作为三达膜环境技术股份有限公司（以下简称"公司"）的独立董事，按照 《公司法》《证券法》《上市公司治理准则》《上海证券交易所科创板股票上市 规则》《国务院办公厅关于上市公司独立董事制度改革的意见》《上市公司独立 董事管理办法》等法律、法规、规范性文件及《公司章程》《独立董事制度》的 有关规定，本人在2023年度的工作中，本着恪尽职守、勤勉尽责的工作态度，认 真行使职权，忠实履行职责，按时出席相关会议，认真审议董事会会议的各项议 案，并基于独立立场对审议的相关事项发表独立客观的意见，充分发挥独立董事 的作用，切实维护公司和股东尤其是中小股东的合法权益。现就2023年度工作情 况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景及任职情况 屈中标，男，1972年出生，中国国籍，无境外永久居留权，毕业于浙江工业 大学，获物流工程系硕士学位，会计学副教授。曾任宁波财经学院教师与会计教 研室主任、宁波工程学院教师，现任本公司独立董事，同时担任厦门理工学院教 师与财务学系主任、厦门三五互联科技股份有限公 ...

Financial Performance - The company reported a total distributable profit of RMB 940,333,960.68 as of December 31, 2023, with a proposed cash dividend of RMB 2.30 per 10 shares, representing a cash dividend payout ratio of 30.07% of the net profit attributable to shareholders[6]. - The company achieved operating revenue of approximately CNY 1.45 billion in 2023, representing a year-on-year growth of 15.20%[22]. - The net profit attributable to shareholders of the listed company was approximately CNY 253.94 million, an increase of 16.55% compared to the previous year[22]. - Basic earnings per share increased by 16.92% to CNY 0.76, while diluted earnings per share also rose by 16.92% to CNY 0.76[23]. - The total assets of the company increased by 4.52% year-on-year, reaching approximately CNY 5.54 billion by the end of 2023[22]. - The company reported a net cash flow from operating activities of approximately CNY 244.62 million, a slight decrease of 1.10% from the previous year[22]. - The company’s total financial assets increased to CNY 799,577,624.49 by the end of the reporting period, reflecting a significant rise from CNY 60,063,457.62 at the beginning[32]. - The company’s total liabilities decreased by 11.99% in contract liabilities to ¥598,924,504.33 from ¥680,517,495.79[124]. Dividend Policy - The board of directors and supervisory board unanimously approved the profit distribution plan, which will be submitted for shareholder approval[7]. - The total share capital as of December 31, 2023, was 333,880,000 shares, with 1,867,934 shares held in the repurchase account, resulting in a base of 332,012,066 shares for the dividend calculation[6]. - The company has established a cash dividend policy that prioritizes cash dividends when conditions permit, with minimum cash dividend ratios set at 80%, 40%, and 20% depending on the company's development stage and capital expenditure plans[183]. - The profit distribution plan has been approved by the board of directors and the supervisory board, and it will be submitted for approval at the shareholders' meeting[185]. - The company does not plan to increase capital reserves or issue bonus shares for the current year[184]. - The company emphasizes the protection of minority shareholders' rights in its cash dividend policy[183]. Research and Development - The company is committed to research and development of high-performance composite membrane materials, including graphene membranes[14]. - Research and development expenses accounted for 4.52% of operating revenue, a decrease of 0.31 percentage points compared to the previous year[23]. - The company has applied for a total of 369 patents, including 212 invention patents and 155 utility model patents, with 239 patents granted as of December 31, 2023[69]. - The total R&D expenditure for the year reached approximately RMB 90.6 million, with a significant portion allocated to the development of various membrane technologies and applications[82]. - The company has established a comprehensive R&D system called "RDPA" (Research-Development-Pilot-Application) focused on membrane technology applications, particularly in wastewater treatment[50]. Market Expansion and Strategy - The company is expanding its market presence through the development of new water treatment technologies and applications[14]. - The company is focused on expanding its overseas market presence and enhancing product and technology research and development efforts[37]. - The company plans to strengthen cooperation with large water service companies and industries such as food, pharmaceuticals, and new energy in 2024, aiming to expand its membrane application market[140]. - The company is actively pursuing new fundraising projects, as evidenced by the approval of new fundraising projects in multiple shareholder meetings[150]. - The company is exploring potential acquisitions to enhance its technological capabilities and market presence, with a focus on companies in the environmental technology sector[156]. Environmental and Social Responsibility - The company is committed to ESG principles, integrating environmental responsibility into its development strategy and actively engaging in social responsibility initiatives[192][194]. - The company invested approximately 4.63 million yuan in environmental protection during the reporting period[196]. - The company operates several key pollutant discharge units across multiple provinces, including Henan, Hubei, and Fujian, which are subject to strict pollution control standards[198]. - The company aims to contribute to sustainable development in the industry and capital markets through its ESG practices[195]. - The company has established a comprehensive governance structure to enhance decision-making fairness and scientific management, ensuring compliance with laws and regulations[195]. Governance and Compliance - The company has established a governance structure in compliance with relevant laws and regulations, ensuring effective operation and risk reduction[143]. - The company maintains independence from its controlling shareholders, with no instances of fund occupation or interference in decision-making[144]. - The company has implemented a strict information disclosure policy, ensuring transparency and equal access to information for all investors[145]. - The company held six shareholder meetings during the reporting period, all of which were legally valid and passed all proposed resolutions without any rejections[151]. - The company has undergone a comprehensive review and upgrade of its governance structure to achieve a more efficient management system[195].

证券代码：688101 证券简称：三达膜 公告编号：2024-020 三达膜环境技术股份有限公司 2023 年度募集资金存放与使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号—上市 公司募集资金管理和使用的监管要求》《上海证券交易所上市公司募 集资金管理办法》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》及相关格式指引的规定，三达膜环境技术股份有 限公司（以下简称"三达膜"或"本公司"）将 2023 年度募集资金存 放与实际使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到位时间 经中国证券监督管理委员会于 2019 年 10 月 16 日出具的《关于 同意三达膜环境技术股份有限公司首次公开发行股票注册的批复》 （证监许可[2019]1925 号）核准，由主承销商长江证券承销保荐有 限公司（以下简称"长江证券保荐机构"）采用向战略投资者定向配 售、网下向符合条件的网下投资者询价配售和网上向持有上海市场非 ...